Maintenance of Clinical and Endoscopic Remission Following Transition From Intravenous to Subcutaneous Infliximab in Inflammatory Bowel Disease: A Real-World Cohort Study

Zymfentra (infliximab-dyyb subcutaneous) - Celltrion

https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=829901&rnd=0.6977924

Megan K. Taylor MD 1; Maya R. Biermann MD 1; Kendra Kamp PhD 1; Nina Saxena MD 2; Mitra Barahimi MD 1; Jeffrey Jacobs MD 1; Kindra Clark-Snustad NP 1; Scott Lee MD 3

Aug 29, 2026